We are live on ! Find out more
AVM

Arch Venture Management Portfolio holdings

AUM $677M
1-Year Est. Return 322.07%
This Fund
S&P 500
This Quarter Est. Return
+9.47%
1 Year Est. Return
+322.07%
3 Year Est. Return
+208.96%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$261M
AUM Growth
-$5.46M
Cap. Flow
-$15.7M
Cap. Flow %
-6.03%
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
BEAM icon
Beam Therapeutics
BEAM
+$15.7M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BEAM icon
1
Beam Therapeutics
BEAM
$2.65B
$118M 45.46%
4,834,653
-608,386
-11% -$15.7M
RAPP
2
Rapport Therapeutics
RAPP
$1.98B
$76.4M 29.31%
3,728,738
– –
ERAS icon
3
Erasca
ERAS
$6.66B
$30.2M 11.58%
11,055,554
– –
QTTB icon
4
Q32 Bio
QTTB
$456M
$14.3M 5.49%
320,482
– –
VERV
5
DELISTED
Verve Therapeutics
VERV
$9.72M 3.73%
2,008,809
– –
GOSS icon
6
Gossamer Bio
GOSS
$68.9M
$7.95M 3.05%
8,055,916
– –
OMIC
7
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$1.98M 0.76%
126,630
– –
UBX
8
DELISTED
Unity Biotechnology
UBX
$1.48M 0.57%
1,004,817
– –
CERO
9
DELISTED
CERo Therapeutics
CERO
$135K 0.05%
722
– –

Similar funds

NI
Noked Israel Ramat Hasharon, Israel $677M AUM 69.37% 1-Year Est. Return
MMPW
Mitchell McLeod Pugh & Williams Mobile, Alabama $678M AUM 23.02% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
NCM
Noesis Capital Mangement Boca Raton, Florida $676M AUM 34.17% 1-Year Est. Return
TWM
Topsail Wealth Management Charlotte, North Carolina $678M AUM 13.87% 1-Year Est. Return
DLIC
Daido Life Insurance Company Osaka, Japan $678M AUM 16.09% 1-Year Est. Return
REAM
Ripple Effect Asset Management New York $679M AUM 81.6% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

Arch Venture Management's Q3 2024 Portfolio in Review

As of Q3 2024, Arch Venture Management held 9 positions worth $261M, down 2.1% from $266M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Arch Venture Management withdrew a net $15.7M in Q3 2024, reducing 1 holding. Its largest reduction was Beam Therapeutics, cutting an estimated $15.7M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Arch Venture Management's biggest Q3 2024 reduction was Beam Therapeutics, cutting an estimated $15.7M.
  • Arch Venture Management's ten largest holdings make up 100% of its $261M portfolio in Q3 2024.
  • Arch Venture Management opened 0 new positions and closed 0 in Q3 2024.
  • Arch Venture Management's portfolio value fell 2.1% quarter-over-quarter to $261M.

Based on Arch Venture Management's 13F filing for Q3 2024, filed 14 Nov 2024.